Richard Mohs
Director/Board Member chez COGSTATE LIMITED
Fortune : 59 010 $ au 31/03/2024
Profil
Richard Mohs is an Independent Non-Executive Director at Cogstate Ltd.
and a Member-Governors Board at Alzheimer's Drug Discovery Foundation.
He is also the Chief Scientific Officer at Global Alzheimer's Platform Foundation, Inc. His former positions include being the VP-Neuroscience Early Clinical Development at Eli Lilly & Co. from 2002 to 2015, a Professor at Icahn School of Medicine at Mount Sinai, and an Associate at James J.
Peters Bronx Veterans Affairs Medical Center.
He holds a doctorate degree from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COGSTATE LTD
0,04% | 30/06/2023 | 67 000 ( 0,04% ) | 59 010 $ | 31/03/2024 |
Postes actifs de Richard Mohs
| Sociétés | Poste | Début |
|---|---|---|
| COGSTATE LIMITED | Director/Board Member | 20/01/2017 |
| Global Alzheimer's Platform Foundation, Inc. | Corporate Officer/Principal | - |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Director/Board Member | - |
Anciens postes connus de Richard Mohs
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2015 |
James J. Peters Bronx Veterans Affairs Medical Center
 James J. Peters Bronx Veterans Affairs Medical Center Hospital/Nursing ManagementHealth Services The James J. Peters Bronx Veterans Affairs Medical Center provides general medical and surgical facility services. The private company is based in New York. | Corporate Officer/Principal | - |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Formation de Richard Mohs
| Stanford University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| COGSTATE LIMITED | Commercial Services |
| Entreprise privées | 3 |
|---|---|
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Health Technology |
| Global Alzheimer's Platform Foundation, Inc. | |
James J. Peters Bronx Veterans Affairs Medical Center
James J. Peters Bronx Veterans Affairs Medical Center Hospital/Nursing ManagementHealth Services The James J. Peters Bronx Veterans Affairs Medical Center provides general medical and surgical facility services. The private company is based in New York. | Health Services |
